INS and Hyperglycemia: In insulin dependent (Type 2) DM, defective insulin secretion can result from impaired β-cell function, oxidative stress [29, 71], the absence of inhibitory feedback through plasma glucagon levels, chronic exposure to free fatty acids [72], lipotoxicity [42], and hyperglycemia [8].